Biotech · Private company · Vienna, VA, US
Nour Heart, Inc.
Track this companyFree. Adds Nour Heart, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart UtilizationFiscal year 2025 · $50KNIH RePORTER 3R44HL174138-01A1S1 · fetched Nov 12, 2026
- Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart UtilizationFiscal year 2025 · $1.9MNIH RePORTER 5R44HL174138-02 · fetched Nov 12, 2026
- Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart UtilizationFiscal year 2024 · $1.7MNIH RePORTER 1R44HL174138-01A1 · fetched Nov 12, 2026